S. Stick, Alexia Foti, R. Ware, H. Tiddens, B. Clements, D. Armstrong, H. Selvadurai, A. Tai, P. Cooper, C. Byrnes, Y. Belessis, C. Wainwright, A. Jaffe, P. Robinson, L. Saiman, P. Sly
{"title":"阿奇霉素对囊性纤维化(COMBAT CF)婴儿结构性肺病的影响:一项随机、双盲、安慰剂对照的3期临床试验","authors":"S. Stick, Alexia Foti, R. Ware, H. Tiddens, B. Clements, D. Armstrong, H. Selvadurai, A. Tai, P. Cooper, C. Byrnes, Y. Belessis, C. Wainwright, A. Jaffe, P. Robinson, L. Saiman, P. Sly","doi":"10.1016/s2213-2600(22)00165-5","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":326030,"journal":{"name":"The Lancet. Respiratory medicine","volume":"25 5","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":"{\"title\":\"The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial.\",\"authors\":\"S. Stick, Alexia Foti, R. Ware, H. Tiddens, B. Clements, D. Armstrong, H. Selvadurai, A. Tai, P. Cooper, C. Byrnes, Y. Belessis, C. Wainwright, A. Jaffe, P. Robinson, L. Saiman, P. Sly\",\"doi\":\"10.1016/s2213-2600(22)00165-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":326030,\"journal\":{\"name\":\"The Lancet. Respiratory medicine\",\"volume\":\"25 5\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Lancet. Respiratory medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/s2213-2600(22)00165-5\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet. Respiratory medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s2213-2600(22)00165-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial.